<DOC>
	<DOC>NCT01958489</DOC>
	<brief_summary>The main purpose of this study is to look at the effect of evacetrapib on pravastatin levels in the blood when both drugs are taken at the same time. The study will also assess how well the body handles evacetrapib and pravastatin when given at the same time. This study has two periods in fixed order. Each participant will enroll in both periods. This study will last approximately 25 days, not including screening.</brief_summary>
	<brief_title>A Study of Evacetrapib in Japanese and Non-Japanese Participants</brief_title>
	<detailed_description />
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Evacetrapib</mesh_term>
	<criteria>Overtly healthy participants, as determined by medical history and physical examination Have a body mass index of 18 to 32 kilograms per square meter (kg/m^2) Japanese participants must be 1st generation Japanese</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>